Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Adalimumab for the treatment of moderate to severe hidradenitis suppurativa: a parallel randomized trial.
A novel series of N-(azetidin-3-yl)-2-(heteroarylamino)acetamide CCR2 antagonists.
Quantitative Susceptibility Mapping in Multiple Sclerosis.
Serum Biomarker gMS-Classifier2: Predicting Conversion to Clinically Definite Multiple Sclerosis.
B-cell targeted therapeutics in clinical development.
Coenzyme Q10 Supplementation Reduces Oxidative Stress and Increases Antioxidant Enzyme Activity in Patients with Relapsing-Remitting Multiple Sclerosis.
[Compensatory mechanisms in multiple sclerosis(review)].
Erratum to: Genomic Binding Sites and Biological Effects of the Vitamin D-VDR Complex in Multiple Sclerosis.
Neural correlates of alerting and orienting impairment in multiple sclerosis patients.
STAT1-induced ASPP2 transcription identifies a link between neuroinflammation, cell polarity, and tumor suppression.
Tumor necrosis factor beta NcoI polymorphism is associated with inflammatory and metabolic markers in multiple sclerosis patients.
Influence of body mass index on psychological and functional outcomes in patients with multiple sclerosis: a cross-sectional study.
24S-hydroxycholesterol in plasma: A marker of cholesterol turnover in neurodegenerative diseases.
Functional connectivity analyses using emulated and conventional resting state data: Parts vs. the whole story.
Optimization of sphingosine-1-phosphate-1 receptor agonists: effects of acidic, basic and zwitterionic chemotypes on pharmacokinetic and pharmacodynamic profiles.
Long-term management of natalizumab discontinuation in a large monocentric cohort of multiple sclerosis patients.
The miR-30a Negatively Regulates IL-17-Mediated Signal Transduction by Targeting Traf3ip2.
An introduction with medical applications to functional data analysis.
A validated regulatory network for Th17 cell specification.
Cortical remyelination: A new target for repair therapies in multiple sclerosis.
Modelling Genetic Susceptibility to Multiple Sclerosis with Family Data.
Lower urinary tract symptoms of neurological origin in urological practice.
The development of myelin repair agents for treatment of multiple sclerosis: Progress and challenges.
Molecular network of chromatin immunoprecipitation followed by deep sequencing-based vitamin D receptor target genes.
Vitamin D and multiple sclerosis.

Pages